Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference25 articles.
1. Arches: a randomized, phase III study of androgen deprivation therapy with enzalutamide or placebo in men with metastatic hormone-sensitive prostate cancer;Armstrong;J. Clin. Oncol.,2019
2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018
3. The Sooner, the better: the establishment of a treatment paradigm in prostate cancer;Buonerba;Front. Pharmacol.,2017
4. Predictors of outcomes in patients with EGFR-Mutated non-small cell lung Cancer Receiving EGFR tyrosine kinase inhibitors: a systematic review and meta-analysis;Buonerba;Cancers,2019
5. Outcomes associated with first-line anti-PD-1/ PD-L1 agents vs. Sunitinib in patients with sarcomatoid renal cell carcinoma: a systematic review and meta-analysis;Buonerba;Cancers,2020
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Second-Line Treatment Options in Metastatic Castration-Resistant Prostate Cancer after Progression on First-Line Androgen-Receptor Targeting Therapies: A Systematic Review and Bayesian Network Analysis;Critical Reviews in Oncology/Hematology;2024-02
2. Updated Review on Analysis of long Non-coding RNAs as Emerging Diagnostic and Therapeutic Targets in Prostate Cancers;Critical Reviews in Oncology/Hematology;2024-02
3. Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironment;European Journal of Medical Research;2024-01-31
4. Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis;Clinical Genitourinary Cancer;2023-10
5. Intermittent Radioligand Therapy with 177Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer;Cancers;2023-09-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3